Atyr Pharma, Stock Price Prediction
| ATYR Stock | 5.30 0.06 1.15% |
Momentum 58
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.19) | EPS Estimate Current Year (0.66) | EPS Estimate Next Year (0.60) | Wall Street Target Price 19.35 | EPS Estimate Current Quarter (0.18) |
Using ATyr Pharma, hype-based prediction, you can estimate the value of aTyr Pharma, from the perspective of ATyr Pharma, response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards ATyr Pharma, using ATyr Pharma,'s stock options and short interest. It helps to benchmark the overall future attitude of investors towards ATyr using crowd psychology based on the activity and movement of ATyr Pharma,'s stock price.
ATyr Pharma, Short Interest
An investor who is long ATyr Pharma, may also wish to track short interest. As short interest increases, investors should be becoming more worried about ATyr Pharma, and may potentially protect profits, hedge ATyr Pharma, with its derivative instruments, or be ready for some potential downside.
200 Day MA 3.8884 | Short Percent 0.2794 | Short Ratio 5.25 | Shares Short Prior Month 18.5 M | 50 Day MA 5.3102 |
aTyr Pharma, Hype to Price Pattern
Investor biases related to ATyr Pharma,'s public news can be used to forecast risks associated with an investment in ATyr. The trend in average sentiment can be used to explain how an investor holding ATyr can time the market purely based on public headlines and social activities around aTyr Pharma,. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of ATyr Pharma,'s market sentiment to its price can help taders to make decisions based on the overall investors consensus about ATyr Pharma,.
ATyr Pharma, Implied Volatility | 3.5 |
ATyr Pharma,'s implied volatility exposes the market's sentiment of aTyr Pharma, stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ATyr Pharma,'s implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ATyr Pharma, stock will not fluctuate a lot when ATyr Pharma,'s options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in ATyr Pharma, to buy its stock at a price that has no basis in reality. In that case, they are not buying ATyr because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ATyr Pharma, after-hype prediction price | USD 5.3 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current ATyr contract
Based on the Rule 16, the options market is currently suggesting that aTyr Pharma, will have an average daily up or down price movement of about 0.22% per day over the life of the 2025-10-17 option contract. With ATyr Pharma, trading at USD 5.3, that is roughly USD 0.0116 . If you think that the market is fully incorporating ATyr Pharma,'s daily price movement you should consider acquiring aTyr Pharma, options at the current volatility level of 3.5%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out ATyr Pharma, Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ATyr Pharma,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ATyr Pharma, After-Hype Price Prediction Density Analysis
As far as predicting the price of ATyr Pharma, at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ATyr Pharma, or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ATyr Pharma,, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ATyr Pharma, Estimiated After-Hype Price Volatility
In the context of predicting ATyr Pharma,'s stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ATyr Pharma,'s historical news coverage. ATyr Pharma,'s after-hype downside and upside margins for the prediction period are 0.27 and 11.42, respectively. We have considered ATyr Pharma,'s daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ATyr Pharma, is risky at this time. Analysis and calculation of next after-hype price of aTyr Pharma, is based on 3 months time horizon.
ATyr Pharma, Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ATyr Pharma, is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ATyr Pharma, backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ATyr Pharma,, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.96 | 6.12 | 0.11 | 0.09 | 8 Events / Month | 3 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
5.30 | 5.30 | 0.00 |
|
ATyr Pharma, Hype Timeline
aTyr Pharma, is presently traded for 5.30. The entity has historical hype elasticity of 0.11, and average elasticity to hype of competition of -0.09. ATyr is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 0.96%. %. The volatility of related hype on ATyr Pharma, is about 6800.0%, with the expected price after the next announcement by competition of 5.21. About 71.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.8. aTyr Pharma, had not issued any dividends in recent years. The entity had 1:14 split on the 1st of July 2019. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days. Check out ATyr Pharma, Basic Forecasting Models to cross-verify your projections.ATyr Pharma, Related Hype Analysis
Having access to credible news sources related to ATyr Pharma,'s direct competition is more important than ever and may enhance your ability to predict ATyr Pharma,'s future price movements. Getting to know how ATyr Pharma,'s peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ATyr Pharma, may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GFL | Gfl Environmental Holdings | (0.09) | 9 per month | 0.00 | (0.1) | 2.03 | (1.95) | 6.87 | |
| MT | ArcelorMittal SA ADR | (0.09) | 9 per month | 1.41 | 0.04 | 3.60 | (2.36) | 9.28 | |
| GMOYF | GMO Internet | 0.00 | 0 per month | 0.00 | (0.12) | 0.00 | 0.00 | 11.34 | |
| TX | Ternium SA ADR | (0.04) | 11 per month | 1.35 | 0.01 | 3.42 | (2.11) | 9.21 | |
| NXPL | Nextplat Corp | (0.03) | 9 per month | 3.66 | 0.11 | 9.59 | (5.71) | 24.66 | |
| SIM | Grupo Simec SAB | 0.00 | 7 per month | 1.16 | (0.07) | 2.02 | (3.12) | 9.17 | |
| PKX | POSCO Holdings | (0.38) | 11 per month | 1.89 | 0.06 | 5.05 | (3.32) | 11.99 |
ATyr Pharma, Additional Predictive Modules
Most predictive techniques to examine ATyr price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ATyr using various technical indicators. When you analyze ATyr charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ATyr Pharma, Predictive Indicators
The successful prediction of ATyr Pharma, stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as aTyr Pharma,, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ATyr Pharma, based on analysis of ATyr Pharma, hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ATyr Pharma,'s market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ATyr Pharma,'s related companies. | 2023 | 2024 | 2025 (projected) | Interest Debt Per Share | 0.28 | 0.18 | 0.17 | Revenue Per Share | 0.006585 | 0.003165 | 0.003006 |
Story Coverage note for ATyr Pharma,
The number of cover stories for ATyr Pharma, depends on current market conditions and ATyr Pharma,'s risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ATyr Pharma, is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ATyr Pharma,'s long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ATyr Pharma, Short Properties
ATyr Pharma,'s future price predictability will typically decrease when ATyr Pharma,'s long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of aTyr Pharma, often depends not only on the future outlook of the potential ATyr Pharma,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ATyr Pharma,'s indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 74.3 M | |
| Cash And Short Term Investments | 72.1 M |
Additional Tools for ATyr Stock Analysis
When running ATyr Pharma,'s price analysis, check to measure ATyr Pharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma, is operating at the current time. Most of ATyr Pharma,'s value examination focuses on studying past and present price action to predict the probability of ATyr Pharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma,'s price. Additionally, you may evaluate how the addition of ATyr Pharma, to your portfolios can decrease your overall portfolio volatility.